Seven days ago, Anthropic emailed bankers an IPO filing and then took the numbers back within hours. I covered that mess here on the 10th, and honestly, I wasn't sure the timetable would survive it.

It did. And then some.

Bloomberg is now reporting the offering is about 7x oversubscribed — orders for roughly 5.8 billion shares, around $450 billion at the top of the range — two days before pricing. If it prices at or above the range, this becomes the biggest share sale ever, ahead of SpaceX's June listing. The company that spent last week retracting its own pricing is now staring at the most oversubscribed IPO of the year.

Here's what we actually know, what's still reported rather than confirmed, and the one number that should keep you honest about the record.

The terms, corrected

The amended S-1 filed on 10 November sets the range at $70–$78 per Class A share, for 825 million shares — about 801.4 million new shares from Anthropic, and about 23.6 million from selling stockholders, including the co-founders. There's a greenshoe for up to 123.75 million more shares.

Do the arithmetic and you get:

  • Up to about $64.4 billion raised in the public offering, before the greenshoe
  • A valuation of up to about $1.405 trillion at the top of the range (about $1.33 trillion at the midpoint, fully diluted)

Those are the corrected numbers. The $70–$80 range and the 867 million shares from the retracted draft are dead — don't quote them, don't build on them. If you see them in a headline today without the caveat, that headline is a week out of date.

The timetable (reported, not confirmed)

Pricing is expected Wednesday 18 November, with first trading Thursday 19 November on the Nasdaq Global Select Market under the ticker ANT. That comes from CNBC, citing people familiar with the deal — the company itself hasn't confirmed the dates, and they can still move.

Two other firsts worth noting: this would be the first standalone frontier AI lab listed on a US exchange, and OpenAI has already ruled out a 2026 IPO. For the next few months, at least, Anthropic is the only pure-play way to own a frontier lab on the public market. That's a big part of why the demand looks like this.

The retail slice is unusually big

Up to 20% of the shares are reserved for retail investors through Schwab, Fidelity, Robinhood, SoFi and E*TRADE. That's roughly double the typical 5–10% retail allocation in a large IPO.

I read that two ways, and both are probably true. One: Anthropic wants a broad shareholder base and a good-news story on listing day. Two: when you're selling 825 million shares, you need every channel working. Retail isn't a favour here — it's distribution.

If you're a developer thinking about buying in, the retail allocation means you probably can. It doesn't mean you should. A 7x oversubscribed book is a statement about demand for shares, not a forecast of where the price goes on Thursday.

The catch: who is buying matters as much as how much

Here's the honest caveat, and it's the part I want you to carry into every conversation about this IPO.

Alongside the public offering sits a separate private placement of about $26 billion, from Anthropic's own suppliers and customers — Google, Nvidia, AMD, Broadcom, Micron, Microsoft and TSMC, per earlier reporting. These are companies that also buy from Anthropic, sell to Anthropic, or both.

That's not an accusation. Strategic investors buying into an IPO is normal, and every one of those names has a genuine commercial reason to want Anthropic to succeed. But it does mean the "biggest share sale ever" record is partly built on money from companies already inside Anthropic's own ecosystem. The headline number and the arms-length demand number are not the same thing, and the honest version of this story says so out loud.

There's a second, quieter point. The retraction last week was a process failure — a filing with wrong pricing reached bankers hours before the roadshow. A 7x book doesn't erase that. It just means investors decided the company is worth more than the embarrassment. Both things can be true at once.

What to watch next

Three things, in order:

  1. The pricing, Wednesday. At the top of the range, at the midpoint, or above the range — each tells a different story about how the book actually held up when it came time to commit.
  2. Thursday's open. The first standalone frontier AI lab trading as ANT. Watch whether the retail allocation steadies the open or adds to the noise.
  3. The private placement, confirmed or not. Whether the $26 billion from the big tech names lands on the reported terms is the real signal about how the industry values Anthropic — louder than any multiple of oversubscription.

I covered the retraction on 10 November because the numbers in it weren't facts. The numbers in this article are facts — they're in the amended S-1, or they're attributed to Bloomberg and CNBC, and the dates are flagged as reported. That's the standard this story has to meet now, after last week.

The roadshow survived its own filing. Now we'll see whether the market agrees with the book.

Would you buy ANT on Thursday, or is a 7x book the moment you'd rather watch from the sidelines?

Sources: Bloomberg (via memeburn, published 2026-11-17T01:27:49Z) — ~7x oversubscribed, ~5.8B shares ordered, ~$450B at $78; Anthropic amended S-1/A No. 2 (10 November 2026) — $70–$78 range, 825M shares (~801.4M new, ~23.6M selling stockholders incl. co-founders), greenshoe up to 123.75M, valuation up to ~$1.405T at top of range; CNBC — pricing expected Wed 18 Nov, first trading Thu 19 Nov on Nasdaq under ticker ANT, dates reported not company-confirmed; Reuters — 9–10 Nov retracted draft filing; earlier reporting — ~$26B private placement (Google, Nvidia, AMD, Broadcom, Micron, Microsoft, TSMC), up to 20% retail allocation via Schwab, Fidelity, Robinhood, SoFi, E*TRADE, biggest share sale ever ahead of SpaceX's June listing, OpenAI ruled out a 2026 IPO. Pricing and trading dates are reported, not company-confirmed, and can move. The ~$90.4B figure seen in some reports was not used — it could not be verified against the filing. No hands-on testing was performed for this article. This breaking article is not the daily buyer-intent post, and it contains no affiliate links.

Previously: Anthropic Sent Bankers Its $69 Billion IPO Pricing — Then Took It Back Hours Before the Roadshow (10 November 2026).